entertainment -WSS

entertainment

author：focus 2025-10-01 23:38:41 - browse：183

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： With heat waves through August, officials warn of health risks

WSS

Kansas bar where gunfire wounded 9 last month closes permanently

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Investment in vaccine development is lagging, report finds

Doctors are clamoring for more clarity on Paxlovid prescribing

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

What does generative AI mean for health care? We asked experts

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Bright Health sells Medicare Advantage business to Molina

How generative AI ratchets up security threats for health systems

Jerome Adams on the need for new antivirals for Covid

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

FDA approval of Sarepta Duchenne genetic therapy gives me hope

St. Louis police protesters begin picking up checks in $4.9 million settlement

Medical records are filled with copy

How CRISPR works, explained in two minutes

explore

St. Louis police protesters begin picking up checks in $4.9 million settlement

Why Medicare shouldn’t cover every FDA

Boston competes with Raleigh

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

The Affordable Care Act has saved billions in health care costs

Philips to halt sales of sleep apnea machines in U.S.

entertainment

Wikipedia

hotspot

focus